Silicon Prairie International Microfluidics Symposium

November 1, 2014

West Campus

University of Kansas, Lawrence, KS

Over 60 people gathered at KU for the Silicon Prairie International Microfluidics Symposium (SPIMS), an afternoon of outstanding short talks by eight experts in the field of microfluidics. SPIMS featured talks by:


Front row, L-R: Sabeth Verpoorte, Prajna Dhar, Cindy Berrie, José Alberto Fracassi da Silva
Back row, L-R: Dulan Gunasekara, Susan Lunte (Director of Adams Institute), Wendell K. T. Coltro, Mei He, Christopher Culbertson

Participants had an opportunity not only to hear about some of the latest research in microfluidics, but also to present their own research at what was an extremely interactive poster session with 18 posters given.  During the poster session, attendees were also provided tours of the Microfabrication and Microfluidics Core facilities in the Multidisciplinary Research Building on KU’s west campus.

    

More information about SPIMS

SPIMS was a great success, thanks to participants who traveled from various parts of Kansas and North Carolina (not to mention Brazil, The Netherlands and Thailand!).


       


    

    

 
A special thank you to our KU sponsors for making this symposium possible!



Recent News

February 2017
CMADP Project Investigators co-author Top Downloaded article in Lab on a Chip

CMADP Co-I awarded R01 from NIH National Cancer Institute

CMADP Graduate's research featured on cover of Genetics and in other journals

October 2016
CMADP Co-I receives Mathers Foundation grant

View all news »

Upcoming Events
Special seminar by Dr. Kevin W. Plaxco
Professor of Chemistry & Biochemistry
UC Santa Barbara

Wednesday, April 19, 2017 at 4:00pm
School of Pharmacy, Room 3020

"Counting molecules, dodging blood cells: real-time molecular measurements directly in the living body"
The development of technology capable of continuously tracking the levels of drugs, metabolites, and biomarkers in situ in the body would revolutionize our understanding of health and our ability to detect and treat disease. It would, for example, provide clinicians with a real-time window into organ function and would enable therapies guided by patient-specific, real-time pharmacokinetics, opening a new dimension in personalized medicine. In response my group has pioneered the development of a “biology-inspired” electrochemical approach to monitoring specific molecules that supports real-time measurements of arbitrary molecular targets (irrespective of their chemical reactivity) directly in awake, fully ambulatory subjects.
KU Today